Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 59,783 |
|
|||||
| News | - | ||||||
| Day High | 2.31 | Low High |
|||||
| Day Low | 2.10 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Immix Biopharma Inc | IMMX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.17 | -7.39% | 2.13 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.31 | 2.10 | 2.31 | 2.13 | 2.30 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 485 | 59,783 | $ 2.17 | $ 129,892 | - | 1.40 - 7.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:36:08 | 10 | $ 2.13 | USD |
Immix Biopharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 42.32M | 19.87M | - | 0 | -15.43M | -0.78 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Immix Biopharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IMMX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.66 | 2.73 | 1.94 | 2.34 | 208,188 | -0.53 | -19.92% |
| 1 Month | 3.00 | 3.23 | 1.94 | 2.66 | 149,313 | -0.87 | -29.00% |
| 3 Months | 3.68 | 4.05 | 1.94 | 3.02 | 264,463 | -1.55 | -42.12% |
| 6 Months | 3.45 | 7.75 | 1.94 | 4.30 | 273,747 | -1.32 | -38.26% |
| 1 Year | 1.82 | 7.75 | 1.40 | 3.40 | 277,747 | 0.31 | 17.03% |
| 3 Years | 5.00 | 8.6799 | 0.68 | 4.16 | 1,205,000 | -2.87 | -57.40% |
| 5 Years | 5.00 | 8.6799 | 0.68 | 4.16 | 1,205,000 | -2.87 | -57.40% |
Immix Biopharma Description
| Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation. |
